Abstract
Purpose : The effects of mosapride citrate were investigated as a gastrokinetic for gastric preparation prior to esophagogastroduodenoscopy (EGD) in the afternoon. Methods : Patients took 15 mg of mosapride citrate immediately after breakfast and then underwent EGD procedures in the afternoon after fasting for six hours. Their stomachs were endoscopically examined for the presence or absence of food residues. Each patient was questioned about distress or hunger pains from fasting. Results : In all 53 patients, no residue remained in their stomachs, and most patients reported no problems in connection with fasting. Conclusion : These findings indicate that mosapride citrate is a good candidate to use for gastric preparation. It is also argued that EGD can be performed safely and implemented successfully in the afternoon.
